Search

Novocure Ltd

Slēgts

SektorsVeselības aprūpe

16.92 -2.48

Pārskats

Akcijas cenas izmaiņa

24h

Šī brīža

Min

16.64

Max

17.36

Galvenie mērījumi

By Trading Economics

Ienākumi

55M

-16M

Pārdošana

9.5M

184M

EPS

-0.13

Peļņas marža

-8.529

Darbinieki

1,605

EBITDA

53M

-11M

Rekomendācijas

By TipRanks

Rekomendācijas

Pirkt

Prognoze 12 mēnešiem

+74.04% upside

Dividendes

By Acuity

Nākamie ieņēmumi

2026. g. 29. okt.

Tirgus statistika

By TradingEconomics

Tirgus kapitalizācija

169M

2B

Iepriekšējā atvēršanas cena

19.4

Iepriekšējā slēgšanas cena

16.92

Ziņu noskaņojums

By Acuity

55%

45%

281 / 340 Rangs Healthcare

Novocure Ltd Grafiks

Pagātnes rezultāti nav uzticams nākotnes rezultātu rādītājs.

Saistītās ziņas

2026. g. 14. aug. 23:21 UTC

Novocure Ltd shares are higher in after-market trading, reversing a three-session decline. No specific company news was identified to explain this movement.

2026. g. 13. aug. 21:01 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a shift in sentiment despite being above the 20-day moving average.

2026. g. 12. aug. 19:41 UTC

Novocure Ltd. shares are lower today, reversing a trend of higher daily closes since Tuesday. Earlier in the session, the stock rebounded from a session high.

2026. g. 11. aug. 20:06 UTC

Novocure Ltd's shares are advancing, remaining above the 20-day moving average amid strong momentum. No specific company news has been identified for the price movement.

2026. g. 10. aug. 21:01 UTC

Novocure Ltd shares are higher in after-market trading, supported by strong performance above the 20-day moving average and within the one-month trading range.

2026. g. 8. aug. 00:01 UTC

Novocure Ltd. shares were roughly flat in after-market hours. The stock is near the lower end of its one-month range, despite being above its 20-day average.

2026. g. 7. aug. 23:11 UTC

Novocure Ltd. shares are lower in after-market trading, reflecting a decline since Friday's close and remaining near the lower end of their one-month range.

2026. g. 6. aug. 19:36 UTC

Novocure Ltd. shares are trading lower, reaching a session low and remaining below the 20-day moving average during Thursday's trading session.

2026. g. 5. aug. 19:56 UTC

Novocure Ltd. shares are lower today, trading below their 20-day moving average and near the lower end of their one-month range.

2026. g. 4. aug. 21:02 UTC

Novocure Ltd. shares are lower in after-market trading, continuing a decline since Tuesday's close amid broader market volatility and fluctuating crude oil prices.

2026. g. 3. aug. 20:06 UTC

Novocure Ltd. shares are higher today, reflecting broader market gains amid positive investor sentiment and declines in oil prices.

2026. g. 31. jūl. 19:46 UTC

Novocure Ltd. shares are lower today, retracing from earlier session highs amid rising bond yields and ongoing inflation concerns. The stock remains below its 20-day moving average.

2026. g. 30. jūl. 19:39 UTC

Novocure Ltd shares are higher today, recovering from an early dip. The stock remains below its 20-day moving average amid a trend of lower closes.

2026. g. 29. jūl. 18:55 UTC

Novocure Ltd's shares are declining today, reversing from a recent trend of higher daily closes. Earlier in the session, the stock briefly rebounded.

2026. g. 28. jūl. 23:31 UTC

Novocure Ltd. shares are lower in after-market hours, continuing a decline over the past four sessions and trading below the 20-day moving average.

2026. g. 27. jūl. 19:06 UTC

Novocure Ltd. shares are lower today amid a broader market decline influenced by a significant drop in crude oil prices.

2026. g. 24. jūl. 19:41 UTC

News
Social Media

Novocure Ltd's stock is lower following its Q2 earnings report, despite a narrower loss and revenue beat. Analysts lowered price targets amid ongoing investor concerns.

2026. g. 22. jūl. 20:04 UTC

Shares of Novocure Ltd. are lower today, continuing a decline since Tuesday's close amid broader market uncertainty ahead of the Federal Reserve meeting.

2026. g. 20. jūl. 14:36 UTC

Novocure Ltd. is trading higher since Friday's close, despite pulling back from an early session high amid broader market volatility from geopolitical tensions.

Salīdzinājums

Cenas izmaiņa

Novocure Ltd Prognoze

Cenas mērķis

By TipRanks

74.04% augšup

Prognoze 12 mēnešiem

Vidējais 29.5 USD  74.04%

Augstākais 52 USD

Zemākais 17 USD

Pamatojoties uz 4 Volstrītas analītiķiem, kuri piedāvā 12 mēnešu cenu mērķi Novocure Ltd — pēdējo 3 mēnešu laikā.

Vērtējuma vienprātība

By TipRanks

Pirkt

4 ratings

2

Pirkt

2

Turēt

0

Pārdot

Noskaņojums

By Acuity

281 / 340 Rangs Veselības aprūpe

Ziņu noskaņojums

Liecība "Lāču" tendencei

Volatilitāte

Zem vidējā

Ziņu apjoms (RCV)

Virs vidējā

Finanšu rādītāji

Pārdošanas un administrēšanas izmaksas

Darbības izmaksas

Peļņa pirms nodokļu nomaksas

Pārdošana

Pārdošanas maksa

Bruto peļņa no pārdošanas

Procentu izdevumi par parādu

EBITDA

Pamatdarbības peļņa

$

Par Novocure Ltd

NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Germany, Japan, Greater China, and internationally. The company's TTFields devices include Optune Gio and Optune Lua. It also has ongoing clinical trials investigating TTFields in brain metastases, gastric cancer, glioblastoma, liver cancer, non-small cell lung cancer, pancreatic cancer, and ovarian cancer. NovoCure Limited was incorporated in 2000 and is headquartered in Baar, Switzerland.
help-icon Live chat